AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

70.902

-0.184-0.26%

Number of Gainers:1

Number of Losers:3

Number of Flat:13

PE:- -

High:72.152

Open:71.559

Low:70.902

Close:71.086

Volume:19.59M

Turnover:565.36K

Market Cap:660.15M

Float Cap:266.79M

Loading ...

Emyria Ltd-FDA Selects Emd to Present at Psychedelic Medicines Hearing

THOMSON REUTERS

Skylark's All-Store Sales Rise 7.2% in August

MT Newswires Live

Emyria Posts FY Net Loss Attributable A$6.1 Million

Emyria - FY Net Loss Attributable A$6.1 Mln

THOMSON REUTERS

Emyria - no Dividends Paid, Recommended or Declared During Fy2026

THOMSON REUTERS

Emyria - FY Revenue from Customer Sales and Clinical Services A$4.1 Mln

THOMSON REUTERS

Elixinol Wellness - no Dividends Paid, Recommended or Declared for H1 FY26

THOMSON REUTERS

Elixinol Wellness - There were no Dividends Paid, Recommended or Declared During the Current Financial Period

THOMSON REUTERS

Elixinol Wellness - H1 FY26 Loss After Tax A$1.07 Mln

THOMSON REUTERS

Elixinol Wellness - Completion Subject to Due Diligence, no Material Adverse Change, and Loan Note Holder Consents

THOMSON REUTERS

Elixinol Wellness - Deal Headline Consideration is A$465,000 Including Upfront, Deferred, Contingent and Earn-Out Payments

THOMSON REUTERS

Elixinol Wellness - Completion Expected in Early September 2026 Subject to Conditions

THOMSON REUTERS

Elixinol Wellness Ltd - Receives Binding Offer for US Divestment

THOMSON REUTERS

Cann Group Ltd-Preliminary Final Report

THOMSON REUTERS

Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026

THOMSON REUTERS

Analysts Have Made A Financial Statement On Botanix Pharmaceuticals Limited's (ASX:BOT) Yearly Report

Simply Wall St.

ECS Botanics Holdings Ltd - FY Net Loss Attributable A$1.9 Mln

THOMSON REUTERS

ECS Botanics Holdings Ltd - no Dividend Has Been Proposed or Declared

THOMSON REUTERS

ECS Botanics Holdings Ltd - FY Revenue from Ordinary Activities A$21.4 Mln

THOMSON REUTERS

Botanix Pharmaceuticals Ltd - no Dividend was Declared or Paid During Year

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BK7502/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7502","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7502\",,,,,undefined,":{"symbol":"BK7502","market":"AU","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":70.9024,"timestamp":1789019914377,"preClose":71.086044,"halted":0,"volume":19590785,"delay":0,"changeRate":-0.002583,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-0.183647,"latestTime":"09-10 16:00:00 AEST","open":71.55943,"high":72.15166,"low":70.9024,"amount":565363,"amplitude":0.017574,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788998400000,1789020000000]],"turnoverRate":0.002207,"increases":1,"decrements":2,"flats":15,"marketCap":660145380,"floatMarketCap":266791070.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7502\",,,,,undefined,":{"symbol":"BK7502","high":72.15166,"amplitude":0.017574,"preClose":71.086044,"low":70.9024,"latestPrice":70.9024,"volume":19590785,"delay":0,"open":71.55943,"prevYearClose":137.30031,"prevWeekClose":71.113,"prevMonthClose":71.078,"prevQuarterClose":68.077,"fiveDayClose":70.834,"twentyDayClose":71.355,"sixtyDayClose":70.899,"secType":"PLATE","market":"AU","turnoverRate":0.002207,"marketCap":660145380,"floatMarketCap":266791070.5,"timestamp":1789019914377,"nameCN":"Cannabis Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7502\",,,,undefined,":{"bkCode":"BK7502","up":1,"down":3,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7502\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666478553","title":"Emyria Ltd-FDA Selects Emd to Present at Psychedelic Medicines Hearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666478553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666478553?lang=en_us&edition=fundamental","pubTime":"2026-09-10 07:35","pubTimestamp":1788996954,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUE5HFXZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7113","EMD.AU","BK7096","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664387212","title":"Skylark's All-Store Sales Rise 7.2% in August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664387212","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664387212?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:14","pubTimestamp":1788509680,"startTime":"0","endTime":"0","summary":"Skylark  recorded a 7.2% year-on-year increase in all-store sales for August, according to its monthly flash report released Friday.Same-store sales rose 4.6%, customer traffic gained 0.4%, and average ticket price  climbed 4.2%.The restaurant chain's operator completed 11 remodels, converted four, and opened seven new stores during the month, bringing its total store count to 3,210.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7131","BK7502","ATP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074943","title":"Emyria Posts FY Net Loss Attributable A$6.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074943","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074943?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:23","pubTimestamp":1788171795,"startTime":"0","endTime":"0","summary":"BRIEF-Emyria Posts FY Net Loss Attributable A$6.1 MillionAug 31 (Reuters)-Emyria LtdEMD.AX:FY NET LOSS ATTRIBUTABLE A$6.1 MILLIONFY REVENUE FROM CUSTOMER SALES AND CLINICAL SERVICES A$4.1 MILLIONNO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING FY2026Further company coverage:EMD.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7113","BK7502","BK7096","EMD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663758030","title":"Emyria - FY Net Loss Attributable A$6.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663758030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663758030?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:39","pubTimestamp":1788165563,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7113","BK7502","EMD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663755580","title":"Emyria - no Dividends Paid, Recommended or Declared During Fy2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663755580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663755580?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:39","pubTimestamp":1788165563,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EMD.AU","BK7096","BK7113","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663755540","title":"Emyria - FY Revenue from Customer Sales and Clinical Services A$4.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663755540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663755540?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:39","pubTimestamp":1788165563,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R01Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7113","EMD.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663502215","title":"Elixinol Wellness - no Dividends Paid, Recommended or Declared for H1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2663502215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663502215?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:57","pubTimestamp":1788155878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R06J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXL.AU","BK7502","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663153022","title":"Elixinol Wellness - There were no Dividends Paid, Recommended or Declared During the Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663153022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663153022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:57","pubTimestamp":1788155878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R06J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","EXL.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663137022","title":"Elixinol Wellness - H1 FY26 Loss After Tax A$1.07 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663137022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663137022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:57","pubTimestamp":1788155878,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R06J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7111","EXL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663802237","title":"Elixinol Wellness - Completion Subject to Due Diligence, no Material Adverse Change, and Loan Note Holder Consents","url":"https://stock-news.laohu8.com/highlight/detail?id=2663802237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663802237?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:36","pubTimestamp":1788154593,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21Z:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","EXL.AU","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663371022","title":"Elixinol Wellness - Deal Headline Consideration is A$465,000 Including Upfront, Deferred, Contingent and Earn-Out Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2663371022","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663371022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:36","pubTimestamp":1788154593,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21Z:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXL.AU","BK7111","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022327","title":"Elixinol Wellness - Completion Expected in Early September 2026 Subject to Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663022327?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:36","pubTimestamp":1788154593,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","EXL.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022320","title":"Elixinol Wellness Ltd - Receives Binding Offer for US Divestment","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663022320?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:36","pubTimestamp":1788154593,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXL.AU","BK7502","BK7111"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663021480","title":"Cann Group Ltd-Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2663021480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663021480?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","CAN.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002145","title":"Cann Group - Net Profit After Tax of A$20.3 Mln for Year Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002145?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:04","pubTimestamp":1788149045,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE4KL5TW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","CAN.AU","BK7502","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663601992","title":"Analysts Have Made A Financial Statement On Botanix Pharmaceuticals Limited's (ASX:BOT) Yearly Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2663601992","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663601992?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:17","pubTimestamp":1787951858,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Limited ( ASX:BOT ) just released its latest yearly report and things are not looking great. It...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/analysts-have-made-a-financial-statement-on-botanix-pharmace","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/analysts-have-made-a-financial-statement-on-botanix-pharmace","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7502","BOT","BK7508","BK7096","BOT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662610039","title":"ECS Botanics Holdings Ltd - FY Net Loss Attributable A$1.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662610039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662610039?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:33","pubTimestamp":1787869999,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1IX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7502","ECS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039643","title":"ECS Botanics Holdings Ltd - no Dividend Has Been Proposed or Declared","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662039643?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:33","pubTimestamp":1787869999,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1IX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","ECS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039617","title":"ECS Botanics Holdings Ltd - FY Revenue from Ordinary Activities A$21.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662039617?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:33","pubTimestamp":1787869999,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1IX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ECS.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662879531","title":"Botanix Pharmaceuticals Ltd - no Dividend was Declared or Paid During Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2662879531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662879531?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:54","pubTimestamp":1787730880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0GV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","BOT.AU","BK7502"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}